Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TTC9-DT (TTC9 Divergent Transcript) is an RNA gene in the human genome belonging to the lncRNA class, encoded on chromosome 14 (hg38 coordinates: chr14:70,608,798-70,641,298)[5][7]. It is predicted to be involved in SRP-dependent cotranslational protein targeting to the membrane and in signal sequence recognition, likely as part of the signal recognition particle (SRP) involved in endoplasmic reticulum targeting[5][7]. TTC9-DT does not encode a protein and currently is not linked to any well-characterized biological or disease roles; therapeutic relevance has not been documented. Its molecular function, disease associations, and potential utility as a biomarker or drug target are largely uncharacterized and may warrant further study[1][5][7].
Not applicable; no drugs known to interact with or modulate TTC9-DT
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TTC9 divergent transcript (TTC9-DT).